endpoint Clinical Revenue and Competitors

Location

$1.7M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • endpoint Clinical's estimated annual revenue is currently $158.7M per year.(i)
  • endpoint Clinical received $1.7M in venture funding in March 2010.
  • endpoint Clinical's estimated revenue per employee is $281,400
  • endpoint Clinical's total funding is $1.7M.

Employee Data

  • endpoint Clinical has 564 Employees.(i)
  • endpoint Clinical grew their employee count by 1% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.4M2-67%N/AN/A
#2
$32M1593%N/AN/A
#3
$35M1213%$62.5MN/A
#4
$30.2M15018%N/AN/A
#5
$135.9M676-1%N/AN/A
#6
$14.9M972%$173MN/A
#7
$110.3M549N/AN/AN/A
#8
$62.7M312-3%N/AN/A
#9
$4.9M4932%N/AN/A
#10
$9.2M46-2%N/AN/A
Add Company

To be the expert, to be the best, you need to immerse yourself in your craft. You need to know every in and out, every up and down every possibility. You need the level of knowledge and understanding that comes from intense dedication and unwavering focus. That's endpoint clinical. Our unique, single-focus approach to IRT solutions transcends the boundaries of traditional IRT providers. We evolve customer insights into action, and leverage the strength of our team and their forward-thinking capabilities to drive continuous innovation for best-in-class IRT. With more than 20 years of experience designing, enhancing and deploying robust, configurable IRT solutions, endpoint is at the forefront of the eClinical technology industry. endpoint. The IRT specialist.

keywords:Biotechnology,Healthcare,Pharmaceuticals

$1.7M

Total Funding

564

Number of Employees

$158.7M

Revenue (est)

1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

endpoint Clinical News

2022-04-17 - Most Blood Cancer Drug Trials Are Not Randomized, Use ...

Most recent clinical trials of drugs for hematologic malignancies are either nonrandomized or use surrogate endpoints, according to a...

2022-04-17 - Amgen's Phase III trial of ABP 654 meets primary efficacy ...

... that the Phase III clinical trial of its ABP 654 in adults with moderate to severe plaque psoriasis met the primary efficacy endpoint.

2022-03-22 - Mapping Endpoints: Is the 6-minute walk test still the best ...

Mapping Endpoints: Is the 6-minute walk test still the best Pompe disease clinical trial endpoint? · Overcoming 6MWT challenges for Pompe disease.

2020-11-19 - endpoint and McCreadie Group Software Integration Reduces Drug Speed to Market and Streamlines Research Pharmacy Workflows

SAN FRANCISCO and ANN ARBOR, Mich., Nov. 19, 2020 /PRNewswire/ -- endpoint Clinical, the leading global interactive response technology (IRT®) company, and McCreadie Group, the market leader in automating manual processes in Investigational Drug Services (IDS), have collaborated to increase stud ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$87.4M564N/AN/A
#2
$99.6M5691%$313M
#3
$35M57010%N/A
#4
$103.5M57117%N/A
#5
$103.5M57117%N/A

endpoint Clinical Funding

DateAmountRoundLead InvestorsReference
2010-03-02$1.7MUndisclosedArticle